Introduction
Scarring of the conjunctiva with a reduction in tear flow occurs in many disorders, though patients are all too often regarded as untreatable or offered only symptomatic relief with artificial tear drops because they are thought to have Sjogren's syndrome or ocular pemphigoid, signs such as transient skin eruptions during long-term treatment having been ignored. Nevertheless, there are often specific changes in the conjunctiva which may enable an accurate diagnosis to be made and the long-term prognosis decided (Jones, 1961) .
Patients
Twenty-seven patients (11 men 16 women) with unusual eye signs and a distinctive pattern of involvement of skin and other organs were seen over 18 months. All were taking practolol for ischaemic heart disease, arrhythmia, or hypertension (see table) , and 19 were also taking diuretics, cardiac glycosides, or anticoagulants The patient's unusual ocular conditions, which resulted from gross reduction in tear flow, had been managed conventionally with artificial tear drops, mucolytics, and control of infection, and routine investigations had shown no systemic cause for the reduced tear flow. The symptoms had proved recalcitrant, and three patients had developed corneal lesions quite unlike those seen in keratoconjunctivitis sicca which caused corneal opacity, perforation, and profound impairment of vision.
EYES
The patients all complained of hot, gritty, foreign-body sensations and photophobia typical of dry eyes (Wright, 1971) roll of subconjunctival tissue adjacent to the limbus and even overhanging the limbus superiorly ( fig. 3) . A reduction in tear flow seemed to have preceded the conjunctival changes in most patients, which together with the absence of secretory IgA and reduction of lysozyme content confirmed the selective effect on the lacrimal glands. The reduction of tear flow produced signs in the precorneal film and marginal tear strip similar to those seen in patients with Sjogren's syndrome. The pattern of staining with Bengal rose, however, was atypical. In many patients staining extended into the lower and upper fornix, where there were areas of thickened conjunctiva with surface changes suggestive of metaplasia or keratinization, which were later confirmed histologically (figs. 4-6).
The corneal changes in the most severely affected patients were unusual. Dense yellow or white opacities appeared suddenly in the central zone of the cornea involving the full thickness of the stroma though without disturbing the epithelium initially ( fig. 7) 1-12 months) . In five patients the eye symptoms preceded any skin signs by an average of seven months (range 1-12 months). Some patients mentioned the rash only on specific questioning because of spontaneous improvement while continuing the drug. Three patients, however, consulted dermatologists, who most commonly found non-irritant raised patches unlike the lesions usually associated with scarring of the conjunctiva. These reddened and scaling patches occurred everywhere except the face. Most patients complained also of thickening and cracking of the palmar skin and hyperkeratosis over the palms, heels, elbows, knuckles, and finger tips, with fissuring of the skin of finger tips. The nails were thickened in one patient and showed psoriasiform changes in another, but the remainder had no nail signs.
OTHER ORGANS
Ear.-Some months after skin and eye lesions appeared 15 patients complained of deafness and tinnitus, and two became profoundly deaf. Simple tests suggested a mixture of conduction defect and cochlear damage and five patients needed surgical treatment for secretory otitis media.
Gut.-One patient was thought to have recurring subacute appendicitis, which had first been noted after two years' treatment with practolol, and two others developed acute intestinal obstruction requiring laparotomy, also after two year's treatment. At operation the whole of the gut was found to be matted together and the appearances were identical to those seen after the fibrous or plastic form of tuberculous peritonitis. A biopsy of the gut of one patient showed nothing specific, and a second episode of intestinal obstruction was managed conservatively.
Mouth and Nose.-Five patients had recurrent ulceration of the oral or nasal mucosa though the classical xerostomia of Sjogren's syndrome was not present.
Investigations
Examination of the tears obtained on cellulose sponges from several patients showed reduction of lysozyme and absence of secretory IgA. Extensive investigation of all the patients failed to show any systemic disorder other than the organ involvement shown in the table. Antinuclear antibodies, often present in high titre, were found in all 27 patients, and a circulating antibody binding to epithelial tissue was found in 25 patients . No other evidence of druginduced systemic lupus erythematosus (S.L.E.) was found, and, in particular, there was no arthralgia, fever, or raised erythrocyte sedimentation rate or blood urea, and lupus erythematosus cells were not seen in peripheral blood.
Lymphocyte transformation studies were performed on two severely affected patients with high titres of antinuclear and intercellular epithelial antibodies but no significant abnormality was found. The DNA-binding capacity of the serum (Hughes, 1971) was investigated in 13 patients and preliminary results suggested an increase within the normal range. Both these investigations will be repeated on this group of patients and reported in more detail.
Treatment and Progress of Lesions
Local management of the dry-eyed state followed the general principles (Wright, 1971) of frequent rehydration with artificial tears (BJ6 or hypromellose eye drops) and local mucolytic drops (acetylcysteine 5% or 10%) to deal with stringy tenacious mucus and control of secondary infection of lid margins and conjunctival sac. Prednisolone 20-40 mg/day was given to two patients, which resulted in rapid improvement of previously persistent skin lesions but had no effect on ocular symptoms or signs. Because of the recent discovery of the antibody binding to epithelial cells and confirmation of its presence in the conjunctiva of three patients severely affected eyes were also treated with intensive local steroid drops (dexamethasone 0 1 %/h), which resulted in a more rapid regression of the signs. In particular, the abnormal proliferating vessels in the subconjunctival tissues seemed less active, and the development of fibrosis, scarring, and conjunctival shrinkage was correspondingly reduced. Local steroids were not used in those cases with progressive comneal stromal melting because steroids can enhance the effect of the locally liberated collagenases which are probably responsible for this type of tissue loss. The intraocular pressure was regularly measured in all patients to detect any steroidinduced rise.
All patients were followed for at least four months two for over a year after stopping practolol, during which time all but one showed uniform improvement in symptoms and signs. The remaining patient (case 3) developed a progressive disorder suggestive of an atypical drug-induced S.L.E. syndrome and was treated with systemic steroids and azathioprine.
The conjunctival signs regressed with disappearance of the abnormal keratinization and reduction of the hyperaemia and vascular abnormalities leaving only a persistent subconjunctival fibrosis. Lacrimal gland function recovered enough for artificial tear drops to be used less often, though most patients still had reduced tear secretion.
Three to four months after stopping the drug the most striking feature was the normal appearance of the conjunctiva. It had become a mobile epithelium moving freely over a deeper subconjunctival fibrous sheet which made the fornices shallower but which was quite unlike the abnormal conjunctiva firmly bound to a dense fibrous mass which produces dense symblepharon in such conditions as mucous membrane pemphigoid. Though they remain at risk from secondary infection, reduced tear flow, and secondary changes in the lids, eyes that have shown adverse reactions to practolol can recover nearly normal function unless severely damaged at the time of the initial drug reaction.
Discussion
Two distinct adverse reactions to practolol have been described. Raftery and Denman (1973) 
